Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis

被引:8
|
作者
Schneider, Hannah [1 ]
Berliner, Dominik [2 ]
Stockhoff, Lena [1 ]
Reincke, Marlene [3 ]
Mauz, Jim B. [1 ]
Meyer, Bernhard [4 ]
Bauersachs, Johann [2 ]
Wedemeyer, Heiner [1 ]
Wacker, Frank [4 ]
Bettinger, Dominik
Hinrichs, Jan B. [4 ]
Maasoumy, Benjamin [1 ]
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol Infect Dis & Endocrinol, Hannover, Germany
[2] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany
[3] Univ Freiburg, Dept Med 2, Med Ctr, Freiburg, Germany
[4] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany
关键词
cardiac decompensation; diastolic dysfunction; liver cirrhosis; TIPS; transjugular intrahepatic portosystemic shunt; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; TIPS; SURVIVAL; IMPACT; ECHOCARDIOGRAPHY; RECOMMENDATIONS; CARDIOMYOPATHY; HEMODYNAMICS; UPDATE;
D O I
10.1002/ueg2.12471
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: About 20% of patients develop cardiac decompensation within the first year after transjugular intrahepatic portosystemic shunt (TIPS) insertion. However, risk factors for cardiac decompensation remain poorly defined. We aimed to evaluate predictors of cardiac decompensation after TIPS insertion in a large, well-defined cohort of patients with liver cirrhosis.Methods: 234 cirrhotic patients who received a TIPS at Hannover Medical School were retrospectively followed up for one year to assess the incidence of cardiac decompensation. Echocardiographic parameters and established diagnostic criteria for cardiac impairment (e.g. by the American Society of Echocardiography/ European Association of Cardiovascular Imaging (ASE/EACVI)) were investigated for an association with cardiac decompensation in a competing risk analysis. Survival was analyzed using a multivariable cox regression analysis adjusting for Freiburg index of post-TIPS survival.Results: Predominant TIPS indication was ascites (83%). Median age was 59 years, median MELD-score 12% and 58% were male. Overall, 41 patients (18%) developed cardiac decompensation within one year after TIPS insertion. Diastolic dysfunction according to the ASE/EACVI was diagnosed in 26% of patients at baseline and was linked to a significantly higher risk for cardiac decompensation (p = 0.025) after TIPS. When investigating individual echocardiographic baseline parameters, only pathological E/A (<0.8 or >2) was identified as a risk factor for cardiac decompensation (p = 0.015). Mortality and liver transplantation (n = 50) were significantly higher among patients who developed cardiac decompensation (HR = 5.29, p < 0.001) as well as in patients with a pathological E/A (HR = 2.34, p = 0.006). Cardiac high-risk status (44% of patients) was strongly linked to cardiac decompensation (HR = 2.93, p = 0.002) and mortality (HR = 2.24, p = 0.012).Conclusion: Cardiac decompensation after TIPS is a frequent and important complication and is associated with reduced survival. American Society of Echocardiography/EACVI criteria and E/A seem to be the best parameters to predict the cardiac risk in cirrhotic patients undergoing TIPS insertion.
引用
收藏
页码:837 / 851
页数:15
相关论文
共 50 条
  • [11] Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
    Jonathan Montomoli
    Peter Holland-Fischer
    Giampaolo Bianchi
    Henning GrФnbk
    Hendrik Vilstrup
    Giulio Marchesini
    Marco Zoli
    World Journal of Gastroenterology, 2010, 16 (03) : 348 - 353
  • [12] Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
    Luo, Xuefeng
    Nie, Ling
    Tsauo, Jiaywei
    Wang, Zhu
    Tang, Chengwei
    Li, Xiao
    KOREAN JOURNAL OF RADIOLOGY, 2013, 14 (03) : 423 - 429
  • [13] Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients
    Su, An Ping
    Cao, Shuang Shuang
    Tian, Bo Le
    Zhang, Zhao Da
    Hu, Wei Ming
    Zhang, Yi
    Wang, Zheng Liang
    Babu, Shah Ram
    Hu, Tao
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (01) : 53 - 59
  • [14] Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt
    March, Christine
    Thormann, Maximilian
    Geipel, Sarah
    Sowa, Jan-Peter
    Ordonez, Felix Barajas
    Pech, Maciej
    Omari, Jazan
    Lemmer, Peter
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [15] Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement
    Liu, Jiacheng
    Ma, Jinqiang
    Yang, Chongtu
    Chen, Manman
    Shi, Qin
    Zhou, Chen
    Huang, Songjiang
    Chen, Yang
    Wang, Yingliang
    Li, Tongqiang
    Xiong, Bin
    RADIOLOGY, 2022, 303 (03) : 711 - 719
  • [16] TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT WITH GASTRIC VEIN EMBOLIZATION IN LIVER CIRRHOSIS
    Korobka, V. L.
    Khoronko, Yu. V.
    Pasechnikov, V. D.
    Korobka, R. V.
    Pak, E. S.
    Malevanny, M. V.
    Pasechnikov, D. V.
    Ashimov, I. A.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2024, 26 (03): : 99 - 110
  • [17] Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals
    Steib, Christian J.
    Li, Hanwei
    Zhang, Jiang
    Mayerle, Julia
    Ricke, Jens
    Gerbes, Alexander L.
    Meyer, Carsten
    Zipprich, Alexander
    Trebicka, Jonel
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (09) : 1179 - 1185
  • [18] Shunt dysfunction and mortality after transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension
    Buettner, Laura
    Pick, Lisa
    Jonczyk, Martin
    Fehrenbach, Uli
    Collettini, Federico
    Auer, Timo Alexander
    Schnapauff, Dirk
    De Bucourt, Maximilian
    Wieners, Gero
    Gebauer, Bernhard
    Aigner, Annette
    Boening, Georg
    INSIGHTS INTO IMAGING, 2024, 15 (01):
  • [19] Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt
    Leng, Xiafei
    Zhang, Feng
    Zhang, Ming
    Guo, Huiwen
    Yin, Xiaochun
    Xiao, Jiangqiang
    Wang, Yi
    Zou, Xiaoping
    Zhuge, Yuzheng
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (07) : 853 - 858
  • [20] Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension Case series
    Zheng, Dan
    Yu, Jiao
    Li, Hui
    Gan, Hongying
    Wang, Jun
    Jiang, Ting
    Ren, Huanping
    Wu, Fan
    MEDICINE, 2021, 100 (27) : E26610